Venus Remedies

Stocks to Watch Today: MCX India, Oberoi Realty, Cipla, Venus Remedies, Dixon Technologies, L&T Finance in focus on 21 January

Stocks To Watch, Jan 21: Stocks like L&T Finance, Sunteck Realty, Jammu and Kashmir Bank, Prakash Industries, Bank of Baroda, Torrent Power, Landmark Cars, Reliance Power, Ugro Capital, REC, Tata Consultancy Services, and Laxmi Dental will be in focus on January 21.

Venus Remedies shares rise 3% as Moldova GMP nod paves way for East Europe expansion

The approval from Moldovan Health Ministry is for Venus' antibiotic-carbapenem facility. The nod for the facility will ensure 'access to high-quality, effective, and reliable antibiotics' across the region, said Venus Remedies.

Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent

Venus Remedies said the authorization is a 'significant milestone' in its journey to strengthen presence in the high-growth market of South-East Asia.

Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine

Its total volume of exports to Ukraine stands at USD 2.20 million. By strengthening its product portfolio in Ukraine, the company aims to increase this figure by 20 per cent in the next one year, a company statement said.

Venus Remedies gets UK approval for chemotherapy drugs

Venus Remedies holds a total of 15 market authorizations for Bleomycin products across the globe.

Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines

The approved drugs include bortezomib, cisplatin, doxorubicin, docetaxel, fluorouracil, and paclitaxel, which are crucial for cancer treatment, according to a company statement.

Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs

Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines movement for another 45 marketing authorisations, and most of these pending approvals are for oncology product.

Venus Remedies trades 2% up on approval to market cancer drugs in Serbia

"The company has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer," the company said in a regulatory filing.

Venus Remedies gains on registering with govt body; to get custom duty exemption

"This exemption will not only enable us to reduce production costs but also empower us to invest more in research and development, enhancing our competitiveness and expanding our global reach," said Saransh Chaudhary, chief of research at Venus Remedies.

Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia

The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said.